US could have saved $1.5 billion on costs with drug pricing linked to benchmark, says research firm
PositiveFinancial Markets

A recent study reveals that the US could have saved $1.5 billion by linking drug pricing to a benchmark system. This finding is significant as it highlights the potential for substantial savings in healthcare costs, which could benefit consumers and the healthcare system overall. By adopting such pricing strategies, the US could improve access to medications and reduce financial burdens on patients.
— Curated by the World Pulse Now AI Editorial System












